In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Annias Immunotherapeutics Inc.

http://www.anniasimmuno.com

Latest From Annias Immunotherapeutics Inc.

Cancer Vaccines: Is There A Future Beyond Trial And Error?

Strong foundational research in immunology and some promising early phase trial results have so far failed to expedite the validation of vaccines to treat cancer. In Vivo examines biopharma’s enduring optimism about the future of cancer vaccinology, including a closer look at one company’s platform to tackle the incurable malignancies that beset the mother of all organs: the human brain.

Innovation ImmunoOncology

Start-Up Previews, May 2015

This Month's Profile Group, Cancer Immunotherapy, features profiles of Annias Immunotherapeutics, Costanoan Immunotherapies, and Unum Therapeutics. Plus these Start-Ups Across Health Care: Glyconics, Metactive Medical, and Navigate Surgical Technologies

BioPharmaceutical Medical Device

Annias Immunotherapeutics Inc.

Every would-be developer of cancer immunotherapeutics faces the same basic problem: how to get the body's immune system to destroy cancerous cells without harming healthy ones. The founders of Annias Immunotherapeutics Inc. think they have found a way to help the body push through immune tolerance and become better able to seek and destroy solid tumors; the trick is targeting a virus that has recently been discovered to be present in certain types of tumors, but not in surrounding healthy tissue.

BioPharmaceutical

Cancer Immunotherapy: Mixing, Matching, And Making Nice

Cancer immunotherapy's potential payoff is big enough that acknowledged competitors are settling disputes, potential competitors are forging alliances, and start-ups like their chances of success. Profiles of Annias Immunotherapeutics, Costanoan Immunotherapies, and Unum Therapeutics.

BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Annias Immunotherapeutics Inc.
  • Senior Management
  • James Sheldon, CEO
  • Contact Info
  • Annias Immunotherapeutics Inc.
    Phone: (919) 929-3688
    3 Sedgewood Rd.
    Chapel Hill, NC 27514
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register